Skip to main content

Table 2 Statistical results of IgE variations during VIT

From: Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

YJ-IgE levels (kUA/L) Group ANOVA Post-Hoc test
NoS vs SP 0–3 NoS vs SP 3–5 SP 0–3 vs SP 3–5
NoS SP 0–3 SP 3–5 F P P P P
(95 % CI) (95 % CI) (95 % CI)
CAP0 5.34 ± 6.26 6.27 ± 6.81 7.27 ± 7.05 1.663 0.192 1.00 (−3.53; 1.66) 0.209 (−4.49; 0.62) 1.00 (−3.65; 1.66)
CAP3 1.91 ± 2.42 3.81 ± 4.62 2.59 ± 2.80 6.261 0.002 0.002 (−3.20; −0.59) 0.616 (−1.96; 0.61) 0.085 (−0.11; 2.55)
CAP5 0.97 ± 1.44 1.15 ± 1.17 2.13 ± 3.11 6.948 0.001 1.00 (−0.98; 0.63) 0.002 (−1.95; −0.36) 0.014 (−1.81; −0.16)
  1. Statistically significant P values are in italics
  2. Mean CAP values (±standard deviation) by group (NoS not stung, SP 0–3, stung and protected within the first 3 years of VIT, SP 3–5 stung and protected in the last 2 years of VIT) and results of statistical analysis